Rhenman & Partners Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-220,000
| Closed | -$3.36M | – | 89 |
|
|
2018
Q2 | $3.36M | Sell |
220,000
-50,000
| -19% | -$763K | 0.34% | 67 |
|
|
2018
Q1 | $6.07M | Sell |
270,000
-68,882
| -20% | -$1.55M | 0.75% | 51 |
|
|
2017
Q4 | $10.2M | Buy |
+338,882
| New | +$10.2M | 1.38% | 27 |
|
|
2017
Q3 | – | Sell |
-30,000
| Closed | -$837K | – | 95 |
|
|
2017
Q2 | $837K | Sell |
30,000
-60,000
| -67% | -$1.67M | 0.12% | 84 |
|
|
2017
Q1 | $3.09M | Buy |
90,000
+20,000
| +29% | +$688K | 0.49% | 69 |
|
|
2016
Q4 | $2.02M | Buy |
70,000
+20,000
| +40% | +$577K | 0.39% | 74 |
|
|
2016
Q3 | $1.59M | Hold |
50,000
| – | – | 0.25% | 85 |
|
|
2016
Q2 | $1.62M | Hold |
50,000
| – | – | 0.29% | 81 |
|
|
2016
Q1 | $1.4M | Sell |
50,000
-70,000
| -58% | -$1.96M | 0.28% | 81 |
|
|
2015
Q4 | $4.28M | Sell |
120,000
-76,000
| -39% | -$2.71M | 0.65% | 55 |
|
|
2015
Q3 | $6.48M | Buy |
196,000
+5,000
| +3% | +$165K | 1.03% | 41 |
|
|
2015
Q2 | $8M | Buy |
191,000
+20,000
| +12% | +$838K | 0.96% | 30 |
|
|
2015
Q1 | $5.57M | Buy |
171,000
+6,000
| +4% | +$196K | 0.94% | 36 |
|
|
2014
Q4 | $5.24M | Sell |
165,000
-54,000
| -25% | -$1.71M | 1.52% | 21 |
|
|
2014
Q3 | $5.42M | Sell |
219,000
-11,000
| -5% | -$272K | 1.59% | 16 |
|
|
2014
Q2 | $5.2M | Buy |
230,000
+53,117
| +30% | +$1.2M | 1.54% | 16 |
|
|
2014
Q1 | $4.3M | Buy |
176,883
+91,883
| +108% | +$2.24M | 1.29% | 22 |
|
|
2013
Q4 | $2.12M | Buy |
+85,000
| New | +$2.12M | 0.83% | 54 |
|